French Post-Marketing Surveillance Survey.

Trial Profile

French Post-Marketing Surveillance Survey.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 13 Aug 2014

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms FR-E-REGISTRY
  • Sponsors Cordis Corporation
  • Most Recent Events

    • 26 Nov 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 06 Mar 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top